No definition available.
Renal agenesis and other reduction defects of kidney
Q17_RENAL_AGENE_OTHER_REDUCT_DEFECTS_KIDNEY
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
174 |
4. Check minimum number of eventsNone |
174 |
5. Include endpointsNone |
174 |
6. Filter based on genotype QC (FinnGen only) |
174 |
Control definitions (FinnGen only)
- Control exclude
- Q17_CONGEN_MALFO_URINARY_SYSTEM
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q6[0-4]
- Name in latin
- Agenesis/aplasia/hypoplasia/atrophia renis/renum
Similar endpoints
↥List of similar endpoints to
Renal agenesis and other reduction defects of kidney
based on the number of shared cases.
Similar with more cases:
- Congenital malformations of the urinary system
- Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly
- Congenital malformations, deformations and chromosomal abnormalities
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1672 | 714 | 949 |
| Only index persons | 1260 | 565 | 695 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.02 | 0.03 |
| Only index persons | 0.02 | 0.02 | 0.03 |
| Median age at first event (years) | |||
| Whole population | 14.59 | 17.97 | 11.61 |
| Only index persons | 24.56 | 26.79 | 22.74 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 174 | 76 | 98 |
| Unadjusted period prevalence (%) | 0.04 | 0.03 | 0.04 |
| Median age at first event (years) | 42.86 | 36.53 | 47.76 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 158
- Matched controls
- 1580
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q60.0
ICD-10 Finland
Renal agenesis, unilateral
+∞
94.5
81
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
90.5
54.0
58
10
Q60.3
ICD-10 Finland
Renal hypoplasia, unilateral
+∞
49.6
45
*
A11CC03
ATC
alfacalcidol; systemic
85.1
47.9
52
9
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
31.7
44.0
59
29
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
60.0
40.9
47
11
A12AA04
ATC
calcium carbonate; oral
113.2
40.1
42
5
127
Kela drug reimbursment
Transplant complication
83.5
39.5
43
7
Z94.0
ICD-10 Finland
Kidney transplant status
73.0
38.7
43
8
N18.8
ICD-10 Finland
Other chronic renal failure
60.1
38.4
44
10
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
434.3
35.4
34
*
137
Kela drug reimbursment
Uraemia requiring dialysis
107.6
32.2
34
*
L04AA06
ATC
mycophenolic acid; systemic
39.7
29.8
37
12
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
79.5
29.2
32
5
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
66.2
28.4
32
6
TK800
NOMESCO Finland
Hemodialysis
63.7
27.4
31
6
B05DA
ATC
Isotonic solutions
107.8
25.5
27
*
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
80.7
24.7
27
*
205
Kela drug reimbursment
Chronic hypertension
6.8
23.8
72
172
B03XA02
ATC
darbepoetin alfa; parenteral
51.4
22.2
26
6
N18.0
ICD-10 Finland
End-stage renal disease
58.9
21.8
25
5
H02AB04
ATC
methylprednisolone; systemic
8.3
21.5
52
88
Q60.4
ICD-10 Finland
Renal hypoplasia, bilateral
+∞
21.3
20
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
12.6
21.2
39
40
C03CA01
ATC
furosemide; systemic
6.1
21.2
69
177
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
126.9
21.1
22
*
L04AD01
ATC
ciclosporin; systemic
21.5
20.5
30
17
Z49.1
ICD-10 Finland
Extracorporeal dialysis
46.7
20.2
24
6
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
53.4
19.8
23
5
Q60.2
ICD-10 Finland
Renal agenesis, unspecified
+∞
19.1
18
*
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
113.7
19.0
20
*
B05DB
ATC
Hypertonic solutions
214.4
19.0
19
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
6.1
18.3
57
134
N19
ICD-10 Finland
Unspecified kidney failure
28.0
17.9
24
10
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
9.1
17.7
39
55
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
56.8
17.4
20
*
Z49.2
ICD-10 Finland
Other dialysis
71.4
17.1
19
*
KA1AE
NOMESCO Finland
Kidney ultrasound examination
23.3
17.0
24
12
M04AA01
ATC
allopurinol; systemic
7.4
16.9
43
76
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
11.4
16.4
31
33
L04AA01
ATC
[U] ciclosporin; systemic
42.8
15.8
19
5
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
176.8
15.8
16
*
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
16.2
15.7
25
18
Z49.0
ICD-10 Finland
Preparatory care for dialysis
63.0
15.1
17
*
196
Kela drug reimbursment
Paricalcitol and cinacalcet
88.5
14.9
16
*
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
88.5
14.9
16
*
C08CA02
ATC
felodipine; oral
8.8
13.8
30
41
C08CA01
ATC
amlodipine; oral
4.0
13.8
69
255
Q61.2
ICD-10 Finland
Polycystic kidney, autosomal dominant
+∞
13.7
13
*
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
31.5
13.3
17
6
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
6.0
13.1
38
79
ZXE20
NOMESCO Finland
More than three and less than five hours
5.2
12.9
43
105
C09AA02
ATC
enalapril; systemic
5.1
12.7
44
112
Q60.5
ICD-10 Finland
Renal hypoplasia, unspecified
+∞
12.7
12
*
TK820
NOMESCO Finland
Peritoneal dialysis
41.1
12.4
15
*
N26
ICD-10 Finland
Unspecified contracted kidney
129.0
11.6
12
*
H05BX01
ATC
cinacalcet; oral
129.0
11.6
12
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
19.6
11.0
16
9
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
7.4
10.6
25
39
7530A
ICD-9 Finland
Congenital anomalies of urinary system, Renal agenesis and dysgenesis[AGENESIA RENIS]
+∞
10.5
10
*
C07AB02
ATC
metoprolol; systemic
4.3
10.2
41
120
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
21.8
10.0
14
7
B03XA01
ATC
erythropoietin; parenteral
21.8
10.0
14
7
R50.9
ICD-10 Finland
Fever, unspecified
3.7
9.8
48
167
204
Kela drug reimbursment
Leukemia lymphatica
19.0
9.6
14
8
V03AE02
ATC
sevelamer; oral
106.1
9.5
10
*
N18
ICD-10 Finland
Chronic kidney disease
106.1
9.5
10
*
M10.9
ICD-10 Finland
Gout, unspecified
7.9
9.4
21
30
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
39.1
9.1
11
*
RD210
NOMESCO Finland
NA
9.5
9.1
18
21
UKC02
NOMESCO Finland
Cystoscopy
4.0
9.1
38
115
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
6.9
9.0
22
36
A49.9
ICD-10 Finland
Bacterial infection, unspecified
5.4
9.0
27
58
N17.9
ICD-10 Finland
Acute renal failure, unspecified
12.6
8.8
15
13
ZXE10
NOMESCO Finland
More than one and less than three hours
2.8
8.6
71
353
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
94.9
8.5
9
*
KC1JB
NOMESCO Finland
Miktiocystography with X-ray
94.9
8.5
9
*
Q62.7
ICD-10 Finland
Congenital vesico-uretero-renal reflux
+∞
8.4
8
*
Q61.48
ICD-10 Finland
Nonspecified renal dysplasia
+∞
8.4
8
*
KA9AE
NOMESCO Finland
Ultrasound examination transplanted kidney
+∞
8.4
8
*
TJA33
NOMESCO Finland
Percutaneous introduction of peritoneal dialysis catheter
+∞
8.4
8
*
J01EA01
ATC
trimethoprim; systemic
3.5
8.2
43
153
WX408
NOMESCO Finland
General anesthesy, balanced
2.9
8.2
61
281
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
6.8
7.8
19
31
XPX08
NOMESCO Finland
Intraoperative flow measurement
47.4
7.8
9
*
V03AE01
ATC
polystyrene sulfonate; oral
26.5
7.7
10
*
V03AE03
ATC
lanthanum carbonate; oral
83.9
7.5
8
*
Z3231
NOMESCO Finland
Registered nurse
2.7
7.4
63
309
TPH04
NOMESCO Finland
Cathetrisation of vein
3.2
7.3
43
166
PBM10
NOMESCO Finland
Closure of arteriovenous fistula of radial artery
+∞
7.3
7
*
Q61.40
ICD-10 Finland
Renal dysplasia of a kidney (multicystic)
+∞
7.3
7
*
Q60.1
ICD-10 Finland
Renal agenesis, bilateral
+∞
7.3
7
*
N39.1
ICD-10 Finland
Persistent proteinuria, unspecified
+∞
7.3
7
*
75301
ICD-8 Finland
Congenital anomalies of urinary system, Agenesis renis unilateralis
+∞
7.3
7
*
Q62.0
ICD-10 Finland
Congenital hydronephrosis
+∞
7.3
7
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.9
7.3
50
216
RS220
NOMESCO Finland
NA
16.8
7.3
11
7
U14
ICPC
Kidney symptom/complaint
16.8
7.3
11
7
R4110
NOMESCO Finland
Physiotherapy
2.8
7.1
53
239
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
4.6
7.1
24
59
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
3.7
6.9
30
93
K65.0
ICD-10 Finland
Acute peritonitis
17.7
6.8
10
6
XF602
NOMESCO Finland
Bloodpressure monitoring
17.7
6.8
10
6
E87.5
ICD-10 Finland
Hyperkalaemia
41.9
6.8
8
*
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
23.7
6.8
9
*
J01MA02
ATC
ciprofloxacin; systemic
2.5
6.6
63
329
Z2446
NOMESCO Finland
Social worker
3.6
6.6
30
97
212
Kela drug reimbursment
Gout
15.1
6.5
10
7
BBA40
NOMESCO Finland
Subtotal parathyroidectomy
72.7
6.5
7
*
RJ411
NOMESCO Finland
NA
72.7
6.5
7
*
KH1EE
NOMESCO Finland
Urologic ultrasound examination
72.7
6.5
7
*
KAS20
NOMESCO Finland
Allogenic transplantation of kidney from living donor
72.7
6.5
7
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
8.7
6.5
13
16
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.2
6.3
23
61
ZXD10
NOMESCO Finland
Scheduled procedure
2.4
6.3
68
377
Z99.2
ICD-10 Finland
Dependence on renal dialysis
27.9
6.3
8
*
RJ421
NOMESCO Finland
NA
+∞
6.3
6
*
KAC10
NOMESCO Finland
Total nephrectomy with capsule
+∞
6.3
6
*
N25.0
ICD-10 Finland
Renal osteodystrophy
+∞
6.3
6
*
75302
ICD-8 Finland
Congenital anomalies of urinary system, Hypoplasia et dysplasia renis
+∞
6.3
6
*
TJW99
NOMESCO Finland
Other minor procedure in gastrointestinal endoscopy
+∞
6.3
6
*
RJ190
NOMESCO Finland
NA
+∞
6.3
6
*
ZXA00
NOMESCO Finland
Right side
2.8
6.2
44
192
C09CA01
ATC
losartan; oral
2.8
6.1
41
174
I10
ICD-10 Finland
Essential (primary) hypertension
2.3
6.0
78
469
ZXE00
NOMESCO Finland
One hour or less
2.4
6.0
72
414
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
75
93
13.42
61.46
10.0
4.1
ng/l
132.5
65.0
4.07
69
87
(3018418) pH of Serum or Plasma
112
361
6.90
35.82
17.4
3.7
ph
7.4
7.4
3.12
31
64
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
32
31
12.42
29.81
8.8
7.1
iu/ml
73.8
703.5
—
5
6
(3000850) Epithelial cells [#/volume] in Urine
93
298
5.56
28.55
9.6
2.6
e6/l
4.4
4.6
0.05
86
260
(3020682) Albumin/Creatinine [Ratio] in Urine
95
328
5.18
26.18
9.9
3.9
mg/mmol
34.8
12.6
1.73
78
211
(3012516) Albumin [Mass/volume] in Urine
91
307
5.12
25.72
8.3
3.1
mg/l
174.3
290.0
0.24
79
197
(3009508) Creatinine [Moles/volume] in Urine
101
380
4.95
24.64
7.9
3.4
mmol/l
6.6
7.9
2.49
93
327
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
117
496
5.15
24.41
11.1
3.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
24
20
13.76
24.36
13.7
3.2
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
63
164
5.45
24.13
9.3
2.3
%
23.2
22.7
0.09
58
147
(3026782) Osmolality of Urine
84
287
4.73
22.87
8.7
2.7
mosm/kgh2o
503.2
574.4
2.32
75
240
(3002582) Erythrocytes [#/volume] in Urine
104
438
4.42
20.97
10.8
3.2
e6/l
106.7
39.9
0.47
96
343
(1616796) Gas panel - Central venous blood
26
31
9.68
20.69
10.5
3.3
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
29
42
8.09
19.75
1.9
1.5
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
95
389
4.18
19.60
9.9
2.9
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
29
43
7.89
19.34
2.0
1.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
112
531
4.11
18.37
4.3
2.5
nmol/l
73.8
73.1
0.11
106
481
(3000991) Gas panel - Venous blood
55
157
4.66
18.35
12.1
8.8
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
93
397
3.88
17.62
10.3
3.0
e6/l
0.1
0.2
0.61
85
308
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
120
608
4.14
17.60
22.3
9.5
mmol/l
1.2
1.2
1.09
114
566
(3018095) Leukocytes [#/volume] in Urine
107
508
3.87
17.15
12.4
3.7
e6/l
32.0
106.3
0.77
97
365
(3026493) Urate [Moles/volume] in Serum or Plasma
79
310
3.84
16.81
6.4
3.5
umol/l
5308.6
3489.7
0.13
74
264
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
39
90
5.30
16.69
15.2
4.5
mmol/l
1.2
1.2
0.42
34
79
(3021901) Oxygen saturation in Capillary blood
21
25
9.42
16.62
7.1
9.8
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
124
663
4.03
16.33
23.4
10.0
mmol/l
1.2
1.2
0.04
109
576
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
47
129
4.62
16.32
9.7
10.9
mmol/l
22.7
23.8
1.74
42
123
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
16
13
13.45
16.25
1.0
1.9
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
17
16
11.67
15.79
1.9
3.5
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
55
178
4.06
15.27
11.2
9.0
mmol/l
0.3
1.4
1.38
46
137
(3024561) Albumin [Mass/volume] in Serum or Plasma
109
561
3.52
14.67
11.6
6.2
g/l
35.1
35.9
0.71
104
528
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
26
46
6.47
14.63
1.4
1.4
u/ml
218.3
167.0
0.46
20
19
(3026008) Bacteria identified in Urine by Culture
82
356
3.47
14.52
3.3
2.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
26
47
6.33
14.31
1.4
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
37
93
4.78
14.21
3.4
2.2
ml/min/173m2
47.3
68.3
1.88
17
37
(3035350) Ketones [Presence] in Urine by Test strip
122
682
3.64
14.20
8.5
3.4
estimate
0.0
0.0
0.00
36
138
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
62
234
3.56
13.55
4.8
2.8
e6/l
0.3
0.9
3.18
45
146
(3012501) Base excess in Blood by calculation
21
32
7.33
13.52
10.6
3.2
mmol/l
2.9
2.7
—
9
23
(3013290) Carbon dioxide [Partial pressure] in Blood
21
32
7.33
13.52
10.6
3.2
kpa
4.8
5.0
0.86
21
32
(40760888) Immunoglobulin light chains.free panel - Serum
16
18
9.69
13.09
1.4
4.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
120
691
3.37
12.75
8.6
3.4
estimate
0.0
0.0
0.00
32
137
(3021601) Nitrite [Presence] in Urine by Test strip
119
683
3.35
12.69
10.4
4.7
estimate
0.0
0.0
0.00
36
142
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
59
224
3.47
12.67
4.7
3.0
e6/l
1.7
2.1
0.15
41
137
(3010421) pH of Blood
21
37
6.32
11.79
11.4
3.1
ph
7.4
7.4
4.77
21
32
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
19
32
6.54
11.12
3.2
5.3
u/ml
0.2
0.3
—
8
23
(3023520) Reticulocytes [#/volume] in Blood
38
117
3.88
11.05
2.0
4.1
e9/l
60.2
68.2
0.60
21
91
(3034860) Kappa light chains.free [Mass/volume] in Serum
17
26
7.14
10.85
1.4
3.7
mg/l
75.4
322.2
—
10
19
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
17
26
7.14
10.85
1.4
3.7
mg/l
52.1
32.3
—
9
19
(3011397) Hemoglobin [Presence] in Urine by Test strip
68
310
2.96
10.44
5.8
3.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
39
134
3.46
9.57
5.6
3.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
18
34
5.79
9.38
2.3
1.6
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
138
947
3.21
9.35
11.2
3.9
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
30
90
3.82
8.97
2.5
4.1
g/l
64.3
66.1
0.71
30
84
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
14
22
6.83
8.67
4.9
2.9
%
58.3
56.9
0.12
14
22
(3030905) Polymorphonuclear cells [#/volume] in Blood
14
22
6.83
8.67
4.3
2.7
e9/l
4.4
4.8
0.15
14
22
(3006184) Hemoglobin [Mass/volume] in Capillary blood
17
33
5.60
8.60
4.5
2.3
g/l
124.0
132.4
0.59
17
24
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
13
19
7.31
8.57
1.1
1.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
25
69
4.06
8.36
1.4
2.8
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
28
86
3.69
8.07
1.6
1.3
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
32
110
3.34
7.77
7.2
11.1
kpa
9.2
9.4
0.28
32
104
(3023368) Bacteria identified in Blood by Culture
66
338
2.53
7.68
8.0
4.6
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
24
69
3.87
7.58
6.5
11.7
%
0.7
0.6
0.21
24
69
(3024928) Oxygen saturation in Venous blood
16
33
5.24
7.57
5.5
24.1
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
125
870
2.55
7.22
10.7
3.8
e6/l
15.2
25.8
—
6
14
(3004119) Hemoglobin [Mass/volume] in Venous blood
26
82
3.55
7.19
6.9
12.0
g/l
119.5
127.4
0.85
26
82
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
40
164
2.87
7.17
9.5
14.1
mmol/l
22.8
24.9
4.39
40
164
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
38
152
2.92
7.12
7.8
9.6
mmol/l
0.2
1.4
1.29
21
109
(3029937) Albumin [Presence] in Urine by Test strip
69
375
2.39
6.94
11.1
3.6
estimate
0.0
0.0
0.00
28
135
(3009343) pH of Capillary blood
38
156
2.84
6.78
8.5
9.5
ph
7.4
7.4
—
13
8
(3052851) Hemolysis interference index of Serum or Plasma
17
41
4.49
6.72
4.0
2.9
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
38
157
2.82
6.69
8.5
9.4
kpa
4.7
5.0
1.62
38
149
(3001122) Ferritin [Mass/volume] in Serum or Plasma
95
606
2.25
6.42
7.4
2.8
ug/l
177.7
104.1
2.65
90
567
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
33
132
2.85
6.15
2.2
1.9
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
33
135
2.78
5.89
2.3
1.9
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
41
189
2.53
5.78
2.8
2.5
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
77
470
2.14
5.61
11.2
7.5
inr
1.2
1.2
0.11
31
158
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
84
532
2.12
5.54
9.8
3.5
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
36
163
2.52
5.24
2.0
1.8
—
—
—
0
0
(3047185) IgG [Mass/volume] in Urine
5
0
+∞
5.23
1.0
0.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
66
393
2.09
5.02
9.2
3.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
11
24
4.83
4.85
1.2
1.5
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
19
63
3.26
4.84
10.5
4.0
%
49.4
54.3
0.32
19
63
(3021440) Promyelocytes/100 leukocytes in Blood
27
110
2.72
4.83
7.0
6.4
%
0.0
0.1
1.08
11
34
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
14
38
3.92
4.75
1.6
1.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
27
111
2.70
4.75
7.0
6.3
%
0.0
0.0
0.49
11
32
(3021589) Normoblasts [#/volume] in Blood
101
713
1.99
4.69
19.9
11.0
e9/l
0.0
0.0
0.64
81
583
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
13
34
4.05
4.62
1.1
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
12
30
4.22
4.51
1.3
1.6
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
12
30
4.22
4.51
1.0
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
12
30
4.22
4.51
1.2
1.8
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
12
30
4.22
4.51
1.3
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
56
327
2.05
4.40
3.4
1.9
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
40
205
2.24
4.38
2.2
2.0
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
8
9
9.25
4.32
6.0
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
28
123
2.52
4.31
13.6
3.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
7
6
12.08
4.31
1.0
1.2
miu/ml
1258.3
1607.8
—
7
6
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
47
260
2.11
4.25
3.4
1.7
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
9
13
7.23
4.22
1.2
1.5
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
79
530
1.90
4.11
6.8
8.0
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
131
1039
2.06
4.08
14.0
7.2
u/l
99.7
90.5
0.82
126
975
(3017181) Myelocytes/100 leukocytes in Blood
27
120
2.48
4.06
7.0
6.0
%
0.3
0.9
1.47
11
38
(3017143) Hepatitis C virus Ab [Presence] in Serum
39
204
2.18
4.05
3.7
1.6
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
105
775
1.89
4.03
9.2
7.2
e9/l
0.0
0.0
0.11
92
680
(3021960) Folate [Moles/volume] in Serum or Plasma
49
281
2.04
4.01
2.0
1.5
nmol/l
21.8
21.5
0.04
44
241
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
14
43
3.45
4.00
1.2
2.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
86
598
1.87
3.96
6.5
4.7
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
14
44
3.37
3.87
1.2
1.9
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
17
61
2.98
3.81
10.9
3.5
mmol/l
23.5
24.4
0.53
17
61
(3001604) Monocytes [#/volume] in Blood
104
774
1.85
3.80
9.3
7.2
e9/l
0.6
0.6
0.50
92
675
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
31
153
2.25
3.69
2.7
4.9
u/l
224.1
290.5
0.91
31
148
(3019198) Lymphocytes [#/volume] in Blood
106
800
1.83
3.64
9.4
7.3
e9/l
1.9
2.0
1.35
94
715
(3013115) Eosinophils [#/volume] in Blood
105
793
1.82
3.57
9.4
7.8
e9/l
0.2
0.2
0.65
93
713
(3019309) Folate [Moles/volume] in Red Blood Cells
37
202
2.06
3.42
1.9
1.6
nmol/l
1373.4
1247.5
0.35
30
155
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
21
90
2.52
3.40
2.6
1.6
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
14
48
3.08
3.38
2.8
1.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
63
415
1.81
3.33
3.5
2.8
—
—
—
0
0
(4035726)
25
118
2.31
3.30
1.7
1.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
7
11
6.58
3.21
1.0
1.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
14
51
2.90
3.06
1.8
1.7
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
5
5
10.24
2.99
13.0
10.8
%
35.5
35.8
—
5
5
(3009871) Measles virus Ab [Titer] in Serum
5
5
10.24
2.99
2.8
2.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
19
83
2.45
2.96
1.8
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
26
131
2.16
2.94
7.4
9.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
9
22
4.25
2.92
1.0
1.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
48
302
1.81
2.90
2.6
2.9
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
66
458
1.71
2.84
2.1
1.8
pmol/l
100.7
93.4
0.70
39
255
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
9
23
4.07
2.81
1.3
1.9
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
24
120
2.16
2.77
2.3
1.6
—
—
—
0
0
(3020891) Body temperature
13
49
2.79
2.69
7.8
4.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
20
94
2.27
2.67
8.9
3.5
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
52
343
1.74
2.66
2.8
2.6
mg/l
3.0
2.9
0.06
43
298
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
8
20
4.14
2.60
1.4
2.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
6
11
5.60
2.56
1.3
1.5
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
22
110
2.14
2.54
5.6
5.6
%
0.5
0.4
—
6
29
(3013650) Neutrophils [#/volume] in Blood by Automated count
111
899
1.65
2.53
10.8
10.6
e9/l
4.3
3.9
1.05
97
798
(3019150) Specific gravity of Urine by Refractometry
47
306
1.73
2.50
8.5
3.5
kg/l
1.0
1.0
—
6
40
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
7
16
4.51
2.50
1.0
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
21
3.94
2.49
1.3
1.5
—
—
—
0
0
(3024932) HLA-DR beta [Type]
5
8
6.39
2.38
1.0
1.4
—
—
—
0
0
(3024471) HLA-A [Type]
5
8
6.39
2.38
1.0
1.0
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
8
6.39
2.38
13.0
7.0
—
—
—
0
0
(3011648) Oxygen content in Venous blood
7
17
4.24
2.38
3.4
38.8
%
11.6
10.9
—
7
17
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
9
28
3.33
2.34
1.9
1.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
51
346
1.67
2.33
10.9
4.7
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
7
18
4.01
2.27
1.3
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
30
3.11
2.18
1.3
1.8
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
13
56
2.43
2.10
6.4
18.5
—
—
—
0
0
(4306422)
6
15
4.10
2.05
1.3
1.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
139
1222
1.68
2.02
5.7
3.7
mmol/l
1.5
1.3
2.35
131
1143
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
49
341
1.61
2.00
1.9
1.8
mmol/l
1.5
1.4
0.50
44
299
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
11
4.64
1.95
1.2
1.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
22
123
1.90
1.91
5.5
12.4
mmol/l
1.0
1.2
0.06
16
99
(21494755) Public health laboratory ask at order entry panel
6
153
0.37
1.87
1.0
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
7
23
3.13
1.82
1.0
1.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
23
133
1.84
1.81
1.3
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
27
166
1.74
1.74
1.4
1.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
13
3.93
1.72
1.4
1.1
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
20
113
1.87
1.69
5.6
13.2
%
91.4
94.9
0.58
20
108
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
8
31
2.65
1.68
1.4
3.5
g/l
37.1
38.2
—
8
26
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
19
3.23
1.67
1.5
1.1
—
—
—
0
0
(44806118)
7
25
2.87
1.67
1.4
1.9
—
—
—
0
0
(44790047)
7
25
2.87
1.67
1.4
1.9
—
—
—
0
0
(44790048)
7
25
2.87
1.67
1.4
1.9
—
—
—
0
0
(44790049)
7
25
2.87
1.67
1.4
1.9
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
33
219
1.63
1.62
2.2
3.0
mmol/l
2.5
2.4
0.39
26
189
(3000492) Spirometry study
6
140
0.41
1.61
1.3
1.5
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
11
50
2.28
1.60
3.9
11.9
mmol/l
24.3
24.1
0.06
11
45
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
157
1451
1.84
1.60
32.1
13.6
mg/l
21.0
22.3
0.20
134
1110
(3025130) Human papilloma virus identified in Specimen
5
15
3.40
1.53
1.4
1.7
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
7
27
2.66
1.53
1.4
1.6
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
7
27
2.66
1.53
1.0
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
7
27
2.66
1.53
1.9
2.0
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
6
21
2.92
1.52
1.3
1.3
—
2.2
—
0
11
(3049717) Cytology report of Urine Cyto stain
9
38
2.44
1.48
4.9
2.6
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
6
137
0.42
1.48
1.2
1.7
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
5
16
3.18
1.45
3.0
2.8
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
6
22
2.79
1.44
1.2
1.2
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
6
22
2.79
1.44
1.3
1.2
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
6
22
2.79
1.44
1.3
1.3
—
2.7
—
0
11
(3019060) Gas panel - Arterial blood
14
74
1.97
1.43
4.8
10.9
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
9
41
2.26
1.39
1.3
3.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
53
404
1.45
1.39
1.6
1.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
139
1260
1.51
1.37
6.4
4.0
mmol/l
1.4
1.4
0.40
132
1173
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
10
47
2.20
1.36
1.5
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
11
54
2.11
1.36
1.0
1.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
54
417
1.43
1.31
7.4
7.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
5
18
2.83
1.29
1.6
1.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
139
1267
1.48
1.26
6.5
4.1
mmol/l
4.4
4.6
1.74
133
1188
(40768797) Stomach Pathology biopsy report
25
165
1.60
1.26
1.2
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
27
182
1.57
1.25
2.0
1.8
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
25
2.45
1.25
1.0
1.0
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
10
49
2.10
1.24
1.5
1.2
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
21
133
1.66
1.24
2.3
3.6
g/l
8.3
9.6
0.85
21
124
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
26
2.35
1.19
1.0
1.0
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
10
50
2.06
1.19
1.5
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
101
880
1.35
1.14
4.5
3.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
8
40
2.05
1.13
1.5
3.0
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
157
1478
1.64
1.12
31.2
12.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
132
1202
1.41
1.11
33.1
11.8
ml/min/173m2
58.8
87.0
14.89
116
958
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
140
1290
1.44
1.08
6.6
4.5
mmol/l
2.5
2.8
3.21
132
1199
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
33
242
1.45
1.05
2.3
1.7
pmol/l
388.5
463.1
0.92
28
213
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
128
1170
1.36
0.98
8.9
5.3
mmol/mol
39.6
39.4
0.08
122
1109
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
0
32
0.00
0.96
0.0
1.0
—
70.5
—
0
6
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
57
468
1.32
0.93
3.5
3.6
ng/l
40.0
36.3
0.13
46
304
(4034850)
8
46
1.77
0.84
15.3
16.8
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
19
131
1.51
0.82
1.6
1.6
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
12
76
1.62
0.74
1.5
1.3
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
7
41
1.74
0.71
1.9
2.1
pmol/l
176.1
222.2
—
7
36
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
5
28
1.81
0.66
2.0
1.6
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
5
28
1.81
0.66
12.8
5.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
102
1106
0.81
0.64
3.7
3.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
11
71
1.59
0.63
3.5
3.9
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
18
242
0.71
0.63
1.9
2.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
8
50
1.63
0.62
2.3
1.8
u/l
43.3
40.5
—
8
45
(3035933) Granulocytes/100 leukocytes in Blood
0
20
0.00
0.61
0.0
1.3
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
21
0.00
0.60
0.0
1.7
—
7.2
—
0
15
(3003327) Ova and parasites identified in Stool by Light microscopy
8
54
1.50
0.58
2.4
1.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
6
39
1.56
0.53
1.7
3.9
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
29
353
0.79
0.53
3.8
4.2
%
23.4
20.6
0.53
14
164
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
6
40
1.52
0.52
1.5
2.5
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
11
75
1.50
0.52
1.2
1.2
—
30.0
—
0
6
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
118
1245
0.84
0.47
6.4
4.1
mmol/l
5.8
5.9
0.15
108
1138
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
12
86
1.42
0.46
2.2
2.3
—
19.1
—
0
5
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
21
261
0.78
0.45
3.2
2.8
ug/l
0.5
0.7
1.65
14
162
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
37
315
1.22
0.45
1.8
2.7
mg/l
0.8
1.4
1.65
30
250
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
5
31
1.63
0.43
1.6
1.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
8
59
1.37
0.41
2.9
1.9
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.9
—
3.3
—
0
6
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.3
—
38.0
—
0
10
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
54
482
1.17
0.40
4.1
2.7
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
120
1257
0.85
0.39
4.3
4.2
mu/l
2.2
1.9
0.38
112
1149
(3008898) HLA-B27 [Presence]
9
67
1.36
0.39
1.2
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
18
221
0.79
0.36
1.8
2.0
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
43
1.41
0.35
1.3
1.6
—
—
—
0
0
(3022621) pH of Urine by Test strip
11
84
1.33
0.31
2.5
2.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
11
141
0.77
0.31
3.5
2.5
nmol/l
15.2
13.0
0.44
11
126
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
15
121
1.26
0.29
1.7
2.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
18
149
1.23
0.29
1.6
1.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
20
234
0.84
0.26
1.5
1.7
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
23
198
1.19
0.26
1.3
1.2
iu/ml
10.1
37.5
—
5
61
(3007164) IgA [Mass/volume] in Serum or Plasma
43
390
1.14
0.26
1.4
1.5
g/l
2.1
2.0
0.04
26
223
(3013707) Erythrocyte sedimentation rate by Westergren method
107
1024
1.12
0.26
5.5
3.9
mm/h
17.6
10.5
2.42
101
946
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
26
227
1.17
0.25
3.8
2.8
ng/l
1595.5
253.9
0.65
20
156
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
9
77
1.18
0.24
1.6
2.7
ng/l
583.4
138.4
—
9
68
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
39
1.29
0.23
1.8
1.3
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
5
40
1.26
0.22
2.2
1.3
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
16
135
1.20
0.22
5.2
2.8
u/l
34.8
31.8
0.16
16
117
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(4027681)
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
12.3
—
10.9
—
0
10
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.6
—
1.1
—
0
12
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
12
0.00
0.21
0.0
1.1
—
33.5
—
0
6
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.0
—
250.8
—
0
6
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.0
—
501.3
—
0
6
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
41
376
1.12
0.21
1.5
1.8
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.1
—
303.8
—
0
13
(21494434) Karyotype in Bone marrow
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
6
50
1.21
0.20
2.0
1.7
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
11
90
1.24
0.19
1.5
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
37
402
0.90
0.19
1.5
1.4
u/ml
0.6
1.1
1.01
13
89
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
62
1.13
0.17
1.6
1.5
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
10
84
1.20
0.14
1.1
1.1
—
—
—
0
0
(3019225) pH of Specimen
12
103
1.18
0.14
11.9
5.0
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
20
180
1.13
0.14
3.4
4.5
umol/l
3.8
8.6
1.57
15
155
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
9
109
0.82
0.13
1.0
1.0
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
16
142
1.14
0.13
15.1
8.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
46
485
0.93
0.12
2.7
2.0
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
13
146
0.88
0.11
1.1
1.2
—
—
—
0
0
(3013512) EKG study
32
340
0.93
0.10
3.5
4.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
7
63
1.12
0.08
1.4
1.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
137
1353
1.06
0.08
25.1
14.9
%
37.7
40.3
3.45
104
1069
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
21
197
1.08
0.06
1.4
1.2
u/ml
2.0
8.3
—
6
73
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
9
103
0.87
0.06
1.4
2.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
18
169
1.07
0.05
1.5
1.4
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
162
1611
1.08
0.03
44.4
19.9
e12/l
4.4
4.6
2.61
156
1566
(3010813) Leukocytes [#/volume] in Blood
162
1613
1.06
0.01
44.4
20.0
e9/l
7.1
6.8
1.16
156
1568
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
43
438
0.98
0.01
4.2
4.9
ug/l
2.3
2.7
0.15
38
395
(4010399)
10
97
1.03
0.00
1.2
1.4
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
11
105
1.05
0.00
1.3
1.4
u/ml
214.2
452.3
0.43
11
94
(3013336) Amino acids [Identifier] in Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
5
50
1.00
0.00
1.6
1.6
—
—
—
0
0
(4198724)
0
9
0.00
0.00
0.0
3.6
—
—
—
0
0
(3022670) pH of Venous cord blood
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
6
67
0.89
0.00
4.2
1.7
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.8
—
18.4
—
0
6
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
0
5
0.00
0.00
0.0
2.2
—
4.3
—
0
5
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
5
0.00
0.00
0.0
22.2
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
(3011048) Pyruvate [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.4
—
97.8
—
0
5
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.2
—
59.2
—
0
6
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049233) Organic acids panel - Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
104.6
—
0
5
(3013139) Helicobacter pylori Ag [Presence] in Stool
8
79
1.01
0.00
1.4
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
4.6
—
77.3
—
0
7
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
0
6
0.00
0.00
0.0
2.5
—
27.1
—
0
6
(3051593) INR in Capillary blood by Coagulation assay
0
5
0.00
0.00
0.0
18.4
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.1
—
129.0
—
0
7
(3006462) Nitrate [Presence] in Urine
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
5.5
—
0
7
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
165.8
—
0
5
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
6
0.00
0.00
0.0
1.2
—
6.0
—
0
6
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
0
8
0.00
0.00
0.0
11.9
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
8
88
0.90
0.00
2.0
1.6
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
0
5
0.00
0.00
0.0
2.2
—
2.6
—
0
5
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
6
59
1.02
0.00
1.8
1.9
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
8
0.00
0.00
0.0
2.4
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
29.0
—
0.6
—
0
8
(4211845)
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
5.0
—
4.5
—
0
5
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
9.0
—
0
6
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.2
—
10.8
—
0
6
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.7
—
1.0
—
0
6
(3026820) Hemoglobin [Mass/volume] in Venous cord blood
0
5
0.00
0.00
0.0
1.0
—
170.4
—
0
5
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint Q17_RENAL_AGENE_OTHER_REDUCT_DEFECTS_KIDNEY and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_RENAL_AGENE_OTHER_REDUCT_DEFECTS_KIDNEY | 3.495 [2.57, 4.75] | < 0.001 |
| Birth year | 0.997 [0.99, 1.01] | 0.485 |
During the follow-up period (1.1.1998 — 31.12.2019), 84 out of 613 females with Q17_RENAL_AGENE_OTHER_REDUCT_DEFECTS_KIDNEY died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_RENAL_AGENE_OTHER_REDUCT_DEFECTS_KIDNEY | 2.759 [2.09, 3.65] | < 0.001 |
| Birth year | 0.986 [0.98, 1.0] | 0.007 |
During the follow-up period (1.1.1998 — 31.12.2019), 106 out of 799 males with Q17_RENAL_AGENE_OTHER_REDUCT_DEFECTS_KIDNEY died.
Mortality risk
Mortality risk for people of age
years, who have Q17_RENAL_AGENE_OTHER_REDUCT_DEFECTS_KIDNEY.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.299% | 0.571% |
| 5 | 2.066% | 2.868% |
| 10 | 5.114% | 7.129% |
| 15 | 10.314% | 13.517% |
| 20 | 17.723% | 22.645% |
Relationships between endpoints
↥Index endpoint: Q17_RENAL_AGENE_OTHER_REDUCT_DEFECTS_KIDNEY – Renal agenesis and other reduction defects of kidney
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data